From the Departments of Medicine (Division of Oncology), Psychiatry and Behavioral Sciences, and Urology, University of Washington School of Medicine, Seattle, WA
Authors disclosures of potential conflicts of interest are found at the end of this article.
Address reprint requests to Celestia S. Higano, MD, Professor, Department of Medicine, University of Washington School of Medicine, 825 Eastlake Ave E, Seattle, WA 98109-1023; e-mail: kgloria{at}u.washington.edu
Overview: Treatments for prostate cancer can result in both sexual and cognitive changes that should be understood and addressed by clinicians. This review will detail those changes and discuss appropriate therapeutic options.